1Mechanisms and clinical research progress in oncotherapy of trilaciclib,a cyclin-dependent kinase 4/6 inhibitorZHENG Xue-qing, ZHANG Li, ZHANG Xiao-tong2329-23382Mechanism of action and clinical research progress of trilaciclib in bone marrow protectionQIAN Min-jia, JIN Ge, FU Ling-ling, XU Min, CHEN He-jian, ZHOU Jian-ying, CHEN Pei-feng2339-23463Research progresses and frontiers of chemotherapy-induced myelosuppression in small-cell lung cancerWU Yu-feng, YU Li-meng, ZHAO Yu-hua, WANG Qi-ming2347-23534Pharmacoeconomics of trilaciclib in the prevention of chemotherapy-induced myelosuppressionLEI Wei-cheng, GUO Chen-chen, DU Bao-ping, LIU Tao, LIANG Wei-ting2354-23595Trilaciclib combined with topotecan as second-line treatment for extensive-stage small-cell lung cancer:a case report and literature reviewYUAN Jing, LU Wei-ping, XIAO Guo-dong, FAN Hui-jie2360-23656First-line trilaciclib combined with immunotherapy plus chemotherapy for extensive-stage small-cell lung cancer:a case report and literature reviewREN Guan-ying, SONG Zi-zheng, WANG Xiao-lei, HU Ling, SONG Jin2366-23697Trilaciclib combined with immunotherapy and chemotherapy for treatment of advanced esophageal cancer:a case report and literature reviewYAN Jing-ze, CHEN Hui, GE Xiao-lin, XIA Xiao-jie2370-23748Patent information analysis of global antitumor drugsZHANG Jing, LI Jing, HU Jie2375-23849Chinese patent analysis of multi-target tyrosine kinase inhibitor regorafenibHONG Meng-shi, LI You2385-239310Progress in target discovery and drug development for non-alcohol fatty liver diseaseSUN Zhao-hui, YANG Zhen-zheng, ZHENG Xiao-nan2394-240211Research progress of biomimetic carrier of cancer cell membrane in tumor therapySONG Xin, XU Bo-hua, WANG Shu-zhe, TAO Qiao-yu, FU Li-li, SUN Lu-yao, QIU Yun-liang2403-241012Retrospective analysis on protocol violation of anti-tumor drug clinical trials from the perspective of ethical reviewZHANG Lei, HAO Chun-yi, LI Jie2411-241613Research on cytotoxicity and mechanisms of natural killer cells combined with lapatinib on breast cancer cells in vitroSUN Yue, YANG Lin, WANG Wen-bang, ZHANG Zhi-fei, JIN Yuan-yuan, YU De-hong, YANG Zhao-yong2417-242414In vitro and in vivo antibacterial activity of doxycycline combined with levofloxacin against carbapenem-resistant Klebsiella pneumoniaeWU Fan, WANG Bao-gui, HU Wen, CHEN Chun-lin2425-243315Data mining of immune checkpoint inhibitors related adverse events of acute kidney injury based on FAERSZHAO Xiao-hong, YAN Ci-lin, PAN Chen, GUO Ming-xing, CUI Xiang-li2434-2440 